Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 85 | BSPED2022 | Next issue

49th Annual Meeting of the British Society for Paediatric Endocrinology and Diabetes

Belfast, Ireland
02 Nov 2022 - 04 Nov 2022

Card image cap
49th Meeting of the British Society for Paediatric Endocrinology and Diabetes

Oral Communications

Oral Communications 9

ea0085oc9.1 | Oral Communications 9 | BSPED2022

Access and use of new technologies in diabetes care in patients that need an interpreter compared to those that do not

Ayya Mekhala , Chizo Agwu Juliana

Young people with Type 1 Diabetes Mellitus (T1DM) can achieve improved glycaemic control by using technology. T1DM technology is steadily improving however access to it remains variable across the UK. Those from ethnic minorities and deprived areas are less likely to access technology and more susceptible to developing complications of diabetes. Understanding the reasons for health inequalities is essential to facilitate use of available technology.Aim: ...

ea0085oc9.2 | Oral Communications 9 | BSPED2022

Audit of management of diabetic ketoacidosis in children at The Noah’s Ark Children’s Hospital for Wales

Ahmed Nagla , Shetty Ambika , Ho Pei

Introduction: Diabetic Ketoacidosis (DKA) is a potentially life threatening complication of type-1 diabetes mellitus (T1DM) in children and young people (CYP). An Integrated Care Pathway (ICP) for management of DKA is based on the current British Society for Paediatric Endocrinology and Diabetes (BSPED) guidelines. The BSPED guideline moved away from cautious fluid replacement toward a liberal approach for resuscitation and maintenance fluids based on current evidence. The ICP...

ea0085oc9.3 | Oral Communications 9 | BSPED2022

Diabetes and obesity in down syndrome across the lifespan: a retrospective cohort study using UK electronic health records

Aslam Aisha , Baksh Asaad , Pape Sarah , Consortium Go-DS21 , Strydom Andre , Gulliford Martin , Chan Li

Background: Down Syndrome (DS) is the commonest form of chromosomal trisomy. Genetic factors in DS may increase the risk for diabetes. Obesity and type 2 diabetes mellitus (T2DM) rates have increased in the general populationbut it is not known whether this similarly affected people with DS.Objective: To determine whether DS is associated with increased incidence of diabetes and the relationship with obesity across the lifespan compared to controls.<...

ea0085oc9.4 | Oral Communications 9 | BSPED2022

Do the UK’s commercially available real-time continuous glucose monitoring devices have robust accuracy data for paediatrics?

Pemberton John

Introduction: NICE Guidance 18 updated in March 2022 will make real-time continuous glucose monitoring (rtCGM) the standard of care and recommends the cheapest rtCGM that meets an individual’s needs. Eight rt-CGM devices have Conformité Européene (CE) mark for paediatrics with type 1 diabetes. There are no published performance standards for CE mark; however, the Food & Drug Administration (FDA) published their interoperable CGM (iCGM) criterion. For iCGM ap...

ea0085oc9.5 | Oral Communications 9 | BSPED2022

Raising awareness of the importance of preconception counselling in young people with diabetes

Green Steve , Dublon Victoria , Meso Muriel , Burchem Melanie , Beesley Avril , Ambridge Jade , Smith Madeleine

Introduction: Pregnancy under the age of 19 is considered high-risk1; and a pregnancy with diabetes at this age further increases that risk2,3. With the correct advice and counselling, these risks can be greatly reduced. Here we describe a strategy to raise awareness by addressing this as part of regular clinic visits.Method: Prior knowledge of potential complications of pregnancy was assessed as part of a clinical consultation. Evi...

ea0085oc9.6 | Oral Communications 9 | BSPED2022

A review of patient outcomes and responses to weight management strategies used by complications from excess weight service, a new paediatric, hospital-based weight management service

Lunat Zainab , Alim Salma , Mulligan Nicola , Joy Niamh , Tang Wing , Skae Mars

In June 2021, NHS England commissioned 15 Complications from Excess Weight (CEW) services to pilot Tier 3 paediatric weight management services in England. This study aimed to assess initial patient experiences / responses to weight management strategies delivered in a single CEW service between January-June 2022.Methodology: We conducted an online survey to assess patient experiences, motivators and barriers to healthy lifestyle change in 45 patients se...

ea0085oc9.7 | Oral Communications 9 | BSPED2022

Liraglutide for the treatment of severe obesity in children: early experiences from a tier 3 paediatric weight management service

Hawton Katherine , Price-Drewett Olivia , Wenn Melanie , Fitzgerald Amy , Hamilton-Shield Julian , Giri Dinesh

Background: Liraglutide is a glucagon-like peptide analogue recently approved for use in children and young people for treating obesity. It is recommended for use within multidisciplinary weight management services, alongside dietetic and lifestyle interventions, in children over 12 years with severe obesity.Aim: To describe our experiences of using liraglutide in a tier 3 paediatric obesity service in a patient cohort who had previously failed to succes...

ea0085oc9.8 | Oral Communications 9 | BSPED2022

Cyclic improvement of a structured education programme teaching dynamic glucose management strategies in children and young people with type 1 diabetes using continuous glucose monitoring

S Pemberton John , P Dias Renuka , Barrett Timothy G , Kershaw Melanie , Krone Ruth , Suma Uday

Background: In 2019, funding for continuous glucose monitoring (CGM) commenced for children and young people with diabetes (CYPD) in our region. However, there was no local established CGM structured education programme. We developed ‘the CGM Academy’ with continuous improvement using the Plan-Do-Study-Act (PDSA) cycle.Objectives: To review the PDSA cycle of improvements to deliver structured education using CGM.Methods: ...